Blog November 18, 2019
How will the Institute for Clinical and Economic Review (ICER) reconcile the tug-of-war between the promise and uncertainty in valuing gene therapies? We dig into this and more in this week’s edition of The Week That Was.
Blog November 15, 2019
Recent headlines amplify anxiety among parents, but behavioral science provides tools to short-circuit these traps.
Blog November 11, 2019
It’s been a little over a year since the first crash of a Boeing 737 Max in Indonesia. We dig into how Boeing leaders are working to rebuild their reputation and more in this week’s edition of The Week That Was.
Blog November 8, 2019
Facebook is launching Preventive Health, a program designed to make its feed-scrollers the world over more health-conscious, especially when it comes to cancer, heart disease, and the flu.
Blog November 5, 2019
On Wednesday, the House Energy & Commerce Committee held a hearing on safeguarding pharmaceutical supply chains in a global economy, and the discussion included something for everyone. Read about the hearing in this week’s edition of The Week That Was.
Blog October 31, 2019
You may know Bose for their cutting-edge speakers and audio tools, but soon they’ll be known for something else. Adding itself to the list of out-of-industry companies breaking into healthcare, Bose makes a big leap with FDA approval for its direct-to-consumer hearing aid.
Blog October 30, 2019
We often forget the importance that language plays with regards to our own and others’ mental health. The words that we choose to use, even if they are synonyms of others, may reflect a bias, negativity or something else: To ourselves and to each other.
Blog October 29, 2019
In an effort to fight atrial fibrillation (AFib), Pfizer and Bristol-Myers Squibb are banding together with, well, a band: Fitbit, the brand behind the popular activity-tracking wristwear that has helped fashion an entire generation of avid sleep-trackers and step-counters.
Blog October 28, 2019
Are U.S. sheriffs PhRMA’s new spokespeople? Learn why not all PR is good PR in this week’s edition of The Week That Was.
Blog October 25, 2019
In a 2017 survey conducted by Ann McKee, a neuropathologist, of 202 former football players’ brains that were donated to science, all but one suffered from Chronic Traumatic Encephalopathy.
Blog October 24, 2019
A global alliance of 17 organizations, headed up by the American College of Sports Medicine (ACSM), published a report advising doctors to prescribe exercise to cancer patients.
Blog October 21, 2019
From potential drug pricing policies to investor interest in life science companies, there’s a lot of talk around money and medicines right now. In this week’s edition of The Week That Was we discuss the current situation and what may be coming for the healthcare industry.
Blog October 18, 2019
EASD—Europe’s largest Diabetes Congress—just wrapped up. Check out 3 things you might have missed.
Blog October 14, 2019
Missed the most recent analysis conducted by ICER? The report details the “drugs whose price increases would have contributed to the largest net increase in drug spending in the US” and more. We have summed up the main takeaways and what they may mean for you.
Blog October 8, 2019
The FDA is expecting to receive more than 200 investigational new drug applications per year for gene therapies, starting in 2020. What does this mean for life science companies? Check out this week’s edition of The Week That Was.
Blog October 4, 2019
Recognizing that the impact of multiple sclerosis (MS) goes beyond the conventionally recognized symptoms, Sanofi has announced a new app to support people with the disease—specifically, their mental health.
Blog October 3, 2019
23andMe, the spit-kit DNA test company that announced a partnership with GSK last year, is embarking on a new health care foray. In partnership with the startup TrialSpark, 23andMe is going to play its part in revolutionizing clinical trials.
Blog September 30, 2019
How could the recent impeachment inquiry effect drug pricing legislation on the Hill? In this week’s edition of The Week That Was, we analyze the possible implications a presidential impeachment would have on drug pricing policy.
Blog September 26, 2019
With mental health drawing an increasing amount of attention, big brands like Starbucks are stepping up to craft a more inclusive workplace with new benefits and policies that put the health of their employees first.
Blog September 25, 2019
Over many years, studies have highlighted how mental health and behaviors affect physical health. Intertwined with this concept we’ve seen new frontiers with behavioral economics, including motivational behavior, navigating biases and irrational behavior.
Blog September 23, 2019
From Sen. Nancy Pelosi’s highly anticipated drug pricing plan to risk-adverse investors, our team shares the latest on the healthcare environment in this week’s edition of The Week That Was.
Blog September 18, 2019
Data is everywhere these days, but what does it look like? The business of data visualization is a vital part of your team’s narrative, and it’s time to give it the attention it deserves.
Blog September 17, 2019
The producers of As Much As I Can, which just finished its run at NoHo’s Joe’s Pub, are the folks at ViiV Healthcare, a group venture formed by Pfizer, GSK and Shionogi, and they hope their play will help ameliorate the plight of people with HIV.
Blog September 16, 2019
Congress is back from summer recess and healthcare is top of mind. Check out our take on which policies could move in this week’s edition of The Week That Was.
Blog September 12, 2019
Global warming is changing the landscape of the world as we know it. With a growing risk for natural disasters, mental health implications as a result of adverse weather events are coming to the forefront of discussions about disaster preparedness.
Blog September 11, 2019
Helping modernize the clinical trials process by leaps and bounds, Janssen is undertaking new initiatives to empower research volunteers.
Blog September 9, 2019
A recent survey found 70% of investors decreased interest in buying IPOs compared to last spring. What does this mean for healthcare companies? Our team digs into the life sciences IPO market and what to watch in this week’s edition of The Week That Was.
Blog September 6, 2019
While general diabetes incidence is declining in the US, several populations aren’t seeing the same progress.
Blog September 5, 2019
In the age of wearables and smartphones, more and more consumers are tracking health-related data on their smart devices. From tracking steps to monitoring your list of medications, Apple’s Health app has been one of the most well-known health trackers on the market.
Blog August 29, 2019
Facebook is hoping that free coffee and privacy check-ins will convince users that it’s prioritizing their data, once again.
Already have a RSS feed reader?
